- Home
- CDIO vs GBR Comparison
CDIO vs GBR Comparison
Compare CDIO & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- GBR
- Stock Information
- Founded
- CDIO 2017
- GBR 1978
- Country
- CDIO United States
- GBR United States
- Employees
- CDIO N/A
- GBR N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- GBR Oil & Gas Production
- Sector
- CDIO Health Care
- GBR Energy
- Exchange
- CDIO Nasdaq
- GBR Nasdaq
- Market Cap
- CDIO 6.4M
- GBR 5.2M
- IPO Year
- CDIO N/A
- GBR N/A
- Fundamental
- Price
- CDIO $3.86
- GBR $1.21
- Analyst Decision
- CDIO
- GBR
- Analyst Count
- CDIO 0
- GBR 0
- Target Price
- CDIO N/A
- GBR N/A
- AVG Volume (30 Days)
- CDIO 21.5K
- GBR 269.3K
- Earning Date
- CDIO 11-12-2025
- GBR 11-12-2025
- Dividend Yield
- CDIO N/A
- GBR N/A
- EPS Growth
- CDIO N/A
- GBR N/A
- EPS
- CDIO N/A
- GBR N/A
- Revenue
- CDIO $19,507.00
- GBR $151,000.00
- Revenue This Year
- CDIO $1,434.82
- GBR N/A
- Revenue Next Year
- CDIO $4,661.91
- GBR N/A
- P/E Ratio
- CDIO N/A
- GBR N/A
- Revenue Growth
- CDIO N/A
- GBR 4.14
- 52 Week Low
- CDIO $3.22
- GBR $0.67
- 52 Week High
- CDIO $53.10
- GBR $1.78
- Technical
- Relative Strength Index (RSI)
- CDIO 51.46
- GBR 66.16
- Support Level
- CDIO $3.58
- GBR $0.95
- Resistance Level
- CDIO $3.98
- GBR $1.26
- Average True Range (ATR)
- CDIO 0.23
- GBR 0.10
- MACD
- CDIO 0.03
- GBR 0.03
- Stochastic Oscillator
- CDIO 66.67
- GBR 86.28
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.